Cochrane · systematic review · CD005041
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
Epstein Tamir, Patsopoulos Nikolaos A, Weiser Mark · Cochrane Database of Systematic Reviews · 2014 · Cochrane Library
Developmental, Psychosocial and Learning ProblemsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
5
current version
GRADE rated
4
No studies
1
Included studies
NR
No studies 1 · 20%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 20%High 3 · 60%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
Population: adults with attention deficit hyperactivity disorder (ADHD)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Hyperactivity | no estimate extracted | 6 studies · 245 participants | High |
Impulsivity | no estimate extracted | 5 studies · 207 participants | High |
Inattentiveness | no estimate extracted | 7 studies · 391 participants | Moderate |
Overall change | no estimate extracted | 9 studies · 455 participants | High |
CI: confidence interval. | no estimate extracted | NR | No studies |